What happens when you take ketoconazole with st. john's wort?
Ketoconazole is an azole antifungal used systemically for serious fungal infections like blastomycosis, coccidioidomycosis, histoplasmosis, and chronic mucocutaneous candidiasis, and topically for dandruff and seborrheic dermatitis. The oral form depends on adequate blood concentrations to inhibit fungal ergosterol synthesis. St. John's Wort (Hypericum perforatum) is a widely sold herbal supplement most often taken for mild depression and seasonal mood changes.
The active constituent hyperforin in St. John's Wort is one of the most potent natural activators of the pregnane X receptor (PXR), a nuclear receptor that, when triggered, ramps up production of CYP3A4 enzymes in the liver and intestine and increases expression of the P-glycoprotein efflux transporter. Over one to two weeks of daily dosing, the body essentially trains itself to clear CYP3A4 substrates much faster than baseline. Ketoconazole is itself extensively metabolized by CYP3A4, so chronic St. John's Wort exposure can lower oral ketoconazole plasma concentrations and shorten its therapeutic effect.
Why is this important?
For serious systemic fungal infections, ketoconazole's antifungal activity is concentration-dependent. If plasma levels drop below the minimum inhibitory concentration for the fungus, the infection can persist, relapse, or develop resistance. This is not a theoretical concern: St. John's Wort is documented to drop blood levels of other CYP3A4 substrates such as cyclosporine, tacrolimus, indinavir, and oral contraceptives by 40 to 60 percent or more. Transplant rejection, HIV virologic failure, and unintended pregnancy have all been reported. The same induction mechanism applies to ketoconazole.
A separate complication is that ketoconazole is itself a strong CYP3A4 inhibitor. In healthy volunteers, when both are dosed together for around a week, ketoconazole's inhibition tends to dominate while both substances are on board. But the picture is dynamic: once ketoconazole is stopped, the underlying enzyme induction from St. John's Wort remains for one to two weeks. This creates a period of accelerated clearance for any other CYP3A4 drug the patient is also taking, even after the antifungal course ends.
Because of this complexity, regulatory bodies and major drug interaction databases list St. John's Wort as contraindicated or to be avoided with ketoconazole. The risk applies most clearly to oral ketoconazole used for systemic disease. Topical ketoconazole shampoo and cream produce minimal systemic absorption, and clinical interaction with St. John's Wort is unlikely with those formulations.
What should you do?
If you have been prescribed oral ketoconazole for a fungal infection, stop taking St. John's Wort before starting the antifungal, and stay off it for at least two weeks after finishing the course. Tell the prescriber if you have been using St. John's Wort daily, because the enzyme induction effect persists for one to two weeks after stopping, and your dose or duration of antifungal may need adjustment, or a non-CYP3A4 antifungal alternative might be selected.
If you currently take St. John's Wort for depression or anxiety, do not stop it abruptly to start an azole antifungal without discussing the situation with the prescribers of both. There are antifungal alternatives that depend less on CYP3A4 metabolism, and there are antidepressant alternatives that do not induce hepatic enzymes.
For topical ketoconazole used for dandruff, athlete's foot, or seborrhea, the systemic exposure is minimal and St. John's Wort interaction is not a practical concern.
Which specific products are affected?
The ketoconazole side includes oral ketoconazole tablets (brand name Nizoral oral, which is now used cautiously due to FDA label restrictions on liver toxicity) and any specialty oral formulation. Ketoconazole shampoo (Nizoral A-D and similar) and ketoconazole cream are minimally absorbed and not affected. The St. John's Wort side includes any standardized hypericum extract from manufacturers such as Nature's Way, Now Foods, Solaray, Gaia Herbs, Kira, Jarrow, and many private-label brands. Standardization to 0.3 percent hypericin or 3 to 5 percent hyperforin does not avoid the induction effect; in fact, higher hyperforin content produces stronger induction.
This warning also extends by analogy to other azole antifungals that depend on CYP3A4 metabolism, including itraconazole and posaconazole. Fluconazole is largely renally excreted and is less affected by St. John's Wort induction.
The bottom line
St. John's Wort can significantly accelerate ketoconazole's breakdown by inducing CYP3A4, lowering antifungal blood levels and risking treatment failure or relapse. Do not combine them. If you take St. John's Wort, disclose it to the prescriber before starting any oral azole antifungal so the regimen can be adjusted or an alternative chosen.